modifi
vaccinia
viru
ankara
mva
highli
attenu
replicationdefici
viru
serv
vaccin
infecti
diseas
assess
vivo
distribut
recombin
mva
candid
vaccin
middl
eastern
respiratori
syndrom
mvamerss
mice
intramuscularli
inocul
mice
necropsi
differ
time
point
examin
histolog
immunohistochemistri
realtim
pcr
detect
inflamm
myonecrosi
parenter
site
hyperplasia
drain
lymph
node
mvamerss
result
detect
lesion
tissu
peripher
parenter
site
drain
lymph
node
realtim
pcr
analysi
tissu
sampl
detect
mvadna
predominantli
inject
site
drain
lymph
node
suggest
continu
clearanc
candid
vaccin
observ
period
level
parenter
site
inflamm
hyperplasia
drain
lymph
node
consid
line
immunolog
respons
vaccin
inocul
modifi
vaccinia
viru
ankara
mva
highli
attenu
vaccinia
viru
serv
wellestablish
viral
vector
system
use
develop
vaccin
infecti
diseas
mva
larg
replicationdefici
mammalian
cell
grow
well
chicken
embryo
fibroblast
nonrepl
mva
vaccin
excel
safeti
profil
preclin
model
use
irradi
rabbit
immunosuppress
macaqu
scid
immunocompet
mice
clinic
test
human
use
differ
inocul
rout
recombin
mva
vaccin
express
full
length
spike
protein
middl
eastern
respiratori
syndrom
coronaviru
mvamerss
prove
suitabl
product
industri
scale
immunogen
protect
merscov
infect
mice
dromedari
wish
gener
addit
preclin
data
vivo
distribut
mvamerss
order
prepar
evalu
mvamerss
vector
vaccin
firstinman
phase
clinic
trial
biodistribut
candid
vaccin
import
estim
risk
potenti
associ
vivo
applic
viru
relev
aspect
includ
monitor
sign
viru
replic
potenti
side
effect
vaccin
select
anim
model
instanc
dispers
viru
parenter
site
inocul
excretori
organ
could
indic
possibl
viral
shed
spillov
gener
environ
although
mva
investig
safe
vector
vaccin
candid
year
mani
studi
regard
distribut
site
peripher
administr
site
studi
assess
distribut
mvamerss
intramuscular
applic
mous
model
use
histolog
immunohistochemistri
pcr
detect
virusassoci
lesion
viral
recombin
antigen
situ
viral
dna
mice
week
old
maintain
specifi
pathogenfre
condit
anim
allow
adjust
facil
one
week
vaccin
experi
perform
free
access
food
water
experi
complianc
german
regul
anim
experiment
anim
welfar
act
mice
inocul
intramuscular
inject
pcrstudi
plaqueform
unit
pfu
histologystudi
mvamerss
control
recombin
mvagfpmcherri
pb
thigh
mice
monitor
daili
sign
diseas
euthan
necropsi
differ
time
point
tabl
full
necropsi
perform
organ
sampl
pcr
histologyimmunohistochemistri
taken
orthopoxvirusspecif
taqmanpcrassay
use
detect
viraldna
sampl
tabl
frozen
dna
isol
use
qiaamp
dna
mini
kit
qiagen
accord
manufactur
instruct
realtim
pcr
qpcr
quantitect
probe
pcr
kit
qiagen
use
quantif
cycl
cutoff
regard
specif
histolog
tissu
fig
paraformaldehydefix
paraffinembed
cut
section
stain
hemalumeosin
skull
rectum
urinari
bladder
taken
h
skull
whole
thigh
decalcifi
antivacvimmunohistochemistri
ihc
perform
tissu
previous
describ
heatinduc
epitoperetriev
antimerssihc
perform
use
polyclon
rabbit
serum
sino
biolog
without
epitoperetriev
ihc
posit
neg
control
includ
macroscop
examin
reveal
swell
left
thigh
muscular
pallor
mild
edema
hemorrhag
swell
drain
lymph
node
macroscop
lesion
organ
attribut
mva
inocul
observ
histolog
time
point
absenc
lesion
attribut
mva
inocul
tissu
parenter
site
drain
lymph
node
fig
earli
time
point
separ
muscl
fiber
inoculum
edema
muscl
fiber
degener
necrosi
parenter
site
interstiti
area
adjac
adipos
tissu
inoculum
predominantli
infiltr
mani
neutrophil
late
time
point
evid
muscular
regener
character
myoblast
tube
intern
nuclei
mani
predominantli
mononuclear
infiltr
interstitia
surround
inoculum
drain
lymph
node
reveal
increas
paracort
lymphocyt
cellular
hyperplasia
vacv
antigen
detect
parenter
site
tissu
includ
drain
lymph
node
reveal
vacv
antigen
vacv
antigen
locat
cytoplasm
spindl
cell
interstitium
fig
phagocyt
cell
macrophag
neutrophil
interstitium
surround
inoculum
merss
antigen
detect
mvamerss
inocul
anim
parenter
site
cytoplasm
similar
spindl
cell
compar
distribut
pattern
fig
drain
lymph
node
display
specif
merss
antigenstain
distribut
sever
lesion
remark
similar
mvamerss
inocul
anim
macroscop
histolog
examin
reveal
similar
find
parenter
site
drain
lymph
node
acut
inflamm
character
edema
mani
infiltr
neutrophil
myofib
degener
necrosi
preval
earli
time
point
later
time
point
infiltr
becam
predominantli
mononuclear
evid
muscl
regener
macroscop
microscop
lesion
organ
attribut
mva
inocul
observ
time
point
vacvantigen
detect
parenter
site
within
cytoplasm
phagocyt
spindl
cell
fig
tissu
includ
drain
lymph
node
reveal
vacv
antigen
macroscop
examin
reveal
lesion
histolog
analysi
display
mild
injectionassoci
lesion
parenter
site
consist
bandlik
degener
singl
muscl
fiber
regener
later
time
point
focal
scarc
interstiti
leukocyt
infiltr
subiliac
lymph
node
one
anim
reveal
mildli
increas
paracort
cellular
histolog
chang
attribut
inocul
detect
tissu
anim
specif
reaction
product
observ
either
two
ihc
histolog
mvamerss
mvadna
detect
mvamerssinocul
mice
parenter
site
ctrang
drain
lymph
node
ctrang
day
day
post
inocul
three
anim
singl
organ
posit
tabl
studi
done
contribut
develop
vaccin
candid
mvamerss
toward
clinic
phase
test
report
data
support
biodistribut
assess
mvamerss
intramuscular
applic
mous
model
regard
system
spread
potenti
excret
side
effect
analyz
tissu
sampl
histolog
immunohistochemistri
qpcr
determin
histolog
candid
vaccin
produc
gener
lesion
organ
lesion
peripher
parenter
site
merssand
vacvantigen
remain
restrict
parenter
site
observ
drain
lymph
node
antivacvihc
reveal
antigen
analyz
peripher
tissu
underlin
incompet
mva
result
gener
spread
inocul
mice
control
viru
mvagfpmcherri
produc
reaction
pattern
indistinguish
mvamerss
underlin
mainten
well
confin
vector
viru
infect
moreov
limit
distribut
mvamerss
confirm
result
qpcr
analysi
detect
relev
amount
mvadna
inject
site
drain
lymph
node
three
anim
high
ctvalu
mvadna
obtain
lung
liver
pcr
signal
probabl
attribut
margin
quantiti
vector
dna
dislodg
parenter
site
similar
studi
also
detect
minim
amount
vector
dna
singl
organ
howev
attempt
mva
reisol
neg
therefor
seem
unlik
signal
repres
viabl
virion
importantli
mvadna
found
excretori
organ
kidney
rectum
includ
fece
urinari
bladder
includ
urin
thu
risk
mva
excret
spillov
genet
modifi
organ
gener
environ
regard
neglig
studi
use
recombin
mva
candid
vaccin
also
report
local
confin
lesion
even
sever
immunosuppress
anim
mvadna
remain
detect
pcr
sever
week
inocul
attempt
isol
infecti
viru
prove
neg
histolog
either
case
reveal
peripher
lesion
associ
mva
inocul
studi
observ
local
inflamm
infiltr
inoculum
adjac
tissu
regard
undesir
reaction
part
physiolog
immun
reaction
vaccin
viru
detect
vacv
antigen
phagocyt
cell
support
effici
vivo
target
antigen
present
cell
follow
inocul
mva
vector
vaccin
degre
extent
inflamm
myonecrosi
studi
accord
ratio
inoculum
volum
relat
parenter
site
mous
muscl
volum
expect
consider
smaller
human
vaccine
hyperplasia
observ
drain
lymph
node
reflect
immun
compet
host
characterist
earli
respons
inflamm
drain
site
conclud
singl
intramuscular
inject
equival
human
dose
mvamerss
mice
without
lesion
tissu
parenter
site
viraldna
found
peripher
organ
except
low
copi
number
detect
singl
sampl
thu
distribut
studi
mice
provid
relev
preclin
data
support
biolog
safeti
mvamerss
candid
vaccin
author
declar
conflict
interest
